Cargando…
Cyclin E1 in Murine and Human Liver Cancer: A Promising Target for Therapeutic Intervention during Tumour Progression
SIMPLE SUMMARY: The cell cycle regulator Cyclin E1 is a key mediator and biomarker of liver cancer progression in mice and man independent of its canonical interacting partner Cyclin-dependent kinase 2. Over-expression of Cyclin E1 during hepatocarcinogenesis modulates several distinct biological pr...
Autores principales: | Sonntag, Roland, Penners, Christian, Kohlhepp, Marlene, Haas, Ute, Lambertz, Daniela, Kroh, Andreas, Cramer, Thorsten, Ticconi, Fabio, Costa, Ivan G., Tacke, Frank, Gassler, Nikolaus, Trautwein, Christian, Liedtke, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8616292/ https://www.ncbi.nlm.nih.gov/pubmed/34830835 http://dx.doi.org/10.3390/cancers13225680 |
Ejemplares similares
-
Pharmacological Inhibition of Cyclin-Dependent Kinases Triggers Anti-Fibrotic Effects in Hepatic Stellate Cells In Vitro
por: Hübbers, Anna, et al.
Publicado: (2020) -
Expression of Cyclin E1 in hepatic stellate cells is critical for the induction and progression of liver fibrosis and hepatocellular carcinoma in mice
por: Otto, Julia, et al.
Publicado: (2023) -
Pro-apoptotic Sorafenib signaling in murine hepatocytes depends on malignancy and is associated with PUMA expression in vitro and in vivo
por: Sonntag, R, et al.
Publicado: (2014) -
Inhibition of Caspase-8 does not protect from alcohol-induced liver apoptosis but alleviates alcoholic hepatic steatosis in mice
por: Hao, Fengjie, et al.
Publicado: (2017) -
Differential impact of the dual CCR2/CCR5 inhibitor cenicriviroc on migration of monocyte and lymphocyte subsets in acute liver injury
por: Puengel, Tobias, et al.
Publicado: (2017)